Batm Advanced Communicat... Share Discussion Threads

[wizzkid211] 17/4/2023 07:01

TIDMBVC

RNS Number : 3449W

BATM Advanced Communications Ld

17 April 2023

LEI: 213800FLQUB9J289RU66

17 April 2023

BATM Advanced Communications Limited

("BATM" or "the Group")

Edgility rollout progressing ahead of schedule

Acceleration of first enterprise deployment and on track for significant FY growth in Edgility revenue

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that the first enterprise deployment of its Edgility edge computing and virtual networking solution is ahead of schedule.

The Group commenced the rollout of Edgility for CEMEX, S.A.B, (NYSE: CX), a leading global construction materials company and the Group's first enterprise customer for Edgility, last year with deployment scheduled to complete in 2024. Following the success to date, with CEMEX's sites throughout a European country having already gone live with the new system, the customer has expedited the global rollout and is now targeting completion this year, thereby accelerating the Group's revenue recognition under this contract.

Alongside this, the Group continues to make excellent progress under its contract with CityFibre, the UK's largest independent carrier-neutral Full Fibre platform, that was signed in October 2022. This includes the customer adopting the Group's latest release of its Edgility platform, which has been expanded to include integrated network functions. Launched to the market earlier this month, the enhanced platform has built-in connectivity functionality that includes virtual Next Generation Firewall (vNGFW) and virtual Router, which is designed to reduce costs for customers compared with bundling devices with external virtual functions as well as to simplify deployment.

The Group expects to receive further orders from CityFibre to enable the rollout of a virtualised solution, which is to replace hardware-based customer premise routing equipment, throughout CityFibre's network.

Moti Nagar, Chief Executive Officer of BATM, said: "We are very excited by the progress that has been made with Edgility. As our customers experience the benefits of our solution, they are looking to accelerate its rollout as well as begin to explore other use cases. The deployment with CEMEX has been very successful and is ahead of schedule while our partnership with CityFibre has resulted in customer-led innovation to launch the latest, enhanced version of our platform. Alongside this, we have continued to earn revenue through our integration partners and are in advanced discussions to expand our Edgility customer base. As a result, our revenue from Edgility in the first quarter of 2023 almost equalled that generated for the whole of 2022, and we remain on track for significant growth in our sales of Edgility this year."

Enquiries:

[susanfrench] 15/4/2023 10:31

It would be good to see the optimism justified & pessimism a thing of the past

[kooba] 15/4/2023 09:30

Late print in 175k at 21.6p could be buyback worked over day i suppose..will see on Monday.

[fse] 14/4/2023 22:09

Anyone reading the news recently might have noticed an uptick in Meningitis cases.
Meningitis is hard to spot emphatically and that in turn means a further problem for prescribing the correct drugs.
Emphatic diagnosis is achieved by a Lumbar Puncture or Spinal tap.
Neither nice or cheap or quick !
ADOR have been working with Meningitis as one of their earlier targets.
The aim is to diagnose and match correct treatment.


A “one-stop-shop” for rapid differential Dx - Meningitis / Encephalitis
---------------------------------------------------------------------

Meningitis / Encephalitis is a medical emergency requiring rapid diagnosis (IVD) and an immediate transfer to the proper treatment.

NATlab Meningitis / Encephalitis Cartridge detects pathogens that cause meningitis with technology based on a multiplex IsoThermal molecular amplification method using sample-to-answer technology from a single CSF sample...

---------------------------------------------------------------------

This assay overcomes the limitation of current diagnostic methods such as CSF culture and latex agglutination assay, with a solution that allows prompt and appropriate treatment of meningitis.

NATlab Meningitis Panel assays allows faster, more reliable and more comprehensive test results than any other products by the innovative NATlab automation platform.

[jackson83] 14/4/2023 14:49

could go lower the 19p's soon




overvalued

[jackson83] 14/4/2023 14:49

opportunity to SELL / SHORT it

[kooba] 14/4/2023 11:12

Its his confidence in putting some of his cash renumeration in ( has likely taken $3-4m ( another $1m taken out of options 100% exercised and out since employed) and currently likely on similar ceo package that gave Zvi $1m in 2021. So should be financially secure to be able to pop a couple of $ in.I did note in the report and accounts that after such a poor performance in 2022 they took zero bonus..if they had it would have been a stretch to justify though !"Dr Marom and Mr. Nagar proposed to waive their right to additional variable remuneration for 2022, which was accepted by the Remuneration Committee."But Moti is on $573k per annum basic and was awarded a very significant share awards package end of last year..so buy even a very modest 100,000 shares would at least get him on the share register. Best practise is now that CEO's build up ( largely out of their own resources not reliant on share incentives) holdings 200-300% of salary over a few years to better aligned themselves with their shareholders.

[kooba] 14/4/2023 10:44

PassoverDate (2023)Evening of Wed, Apr 5, 2023 - Evening of Thu, Apr 13, 2023Well that is out of the way ..the price is lower than last price paid in the buyback 22.4p in Dec but there has been no buy back under the new and improved regime..so as much as Moti might have lots of super new ideas yet to be announced as everything so far is cut and pasted from the last few years...is using company cash to buy shares back something he is keen on ? We will have to wait and see. Moti still retains the title of the only executive director now ceo of any UK listed company that does not own a single share in their own name after more than a year let alone 8 years.hip hip.....

[gbenson1] 14/4/2023 09:32

We had a similar fall to the 20p region in Dec and bounced off that, mainly due to the Co deciding to restart the share buyback which I guess is a level the co are happy buying back stock, or being cynical it's a level short term trader are willing to dive in for their 30-40% bounce!!

[resistance1] 14/4/2023 08:50

I’m calling yesterday the share price floor. We will see in next 2 weeks if I’m right. Tempted to snap up a few more to average down some more (av still far too high.) However have to sell other (loss making) investments to do so. Jury out but such an attractive price. Don’t want to be kicking myself in 6-months…

[kooba] 13/4/2023 17:22

Well I'm still here and waiting for something to happen , i find it amusing that folk are so excited by a couple of comments from the long term executive Moti in this years accounts..like everything it is just rinse and repeat stuff.. if one looked at the 2021 statement i doubt you would expect to be where we are now..we have a smaller business , smaller profit , no real inflection points and no corporate transactions and a massive miss on expectations..no signs of a new dawn to me.Agree with echo ..cyber wont go anywhere yet..it strikes me there are two businesses cyber/telco and medical diagnostics and distribution , neither reliant on each other but could cross fertilise in those groups. Anyway will go back to sleep until there is actually something new.2021 report and accounts"Looking ahead, we entered the new year with sustained momentum across the business and we remain on track to deliver significant growth for full year 2022, in line with market expectations. We have established solid foundations in core technologies that are now at an inflexion point of becoming market disrupters. We will continue to cultivate growth and development across our business as well as pursue opportunities to accelerate the realisation of the value of the IP within our different units through strategic transactions. We have an exciting future ahead of us and we look forward to reporting on our progress and delivering value for our shareholders."

[car1pet] 13/4/2023 09:48

I read all these positive posts about IP, strategy cash etc and look at the share price Current spread 20.6 /21p.
Are you all living in an alternative reality? The market rules and its not seeing a positive outlook. Why didn't I sell at 30p!!!
There is clearly a serious problem with this company

[paulisi] 13/4/2023 09:44

Distribution is the obvious sell off.Zvi has mentioned this in a previous podcast.According to the annual report, I would expect the new CEO to report to the markets in the next few weeks the grand plan.

[resistance1] 13/4/2023 09:03

Wizz is this in the annual report? Where did you get intel? If approved great way to leverage ‘military grade’ encryption IP

[wizzkid211] 13/4/2023 08:47

A civilian version is waiting for a government license.

[echoridge] 13/4/2023 08:13

Cyber is very unlikely for sale in any case, at least at the moment. In fact, as I've written before, I'm pretty confident that management are much more likely focused on growing that business by developing a commercially attractive, civilian version(s) of its currently successful, but classified product(s) being used by the Israeli government. If this proves impossible however, then yes, it may then be deemed expendable, especially as this business is growing and profitable and there are several, much larger software companies focused almost exclusively on serving the government that would create a decent sale price. Fwiw, I continue to think the most likely businesses currently topping the For Sale list are Distribution within BioMed and/or the Carrier Ethernet business within Networking (the latter is my no1 pick as it has been a solid performer for near decades, with industry-leading margins and is likely seen as post-growth).

[resistance1] 13/4/2023 07:07

Selling the Cyber maybe restricted to Israeli companies only — might limit value.

[paulisi] 12/4/2023 22:19

This is interesting from the full year doc and something, I've not seen in this detail. It is quite obvious which subsidiaries are which25 SubsidiariesA list of the significant direct and indirect investments in subsidiaries, including the country of incorporation, and percent of ownership interest as at 31 December 2022 is presented below.SubsidiaryPrincipal activityCountry of incorporationOwnership interestDate of acquisitionEntity A Telecommunication United States of America 100% April 2000Entity B Distribution Romania 100% June 2007Entity C Eco-Med Hungary 100% February 2008Entity D Distribution Moldova 51% July 2008Entity E Diagnostics Italy 96% February 2009Entity F Diagnostics Italy 96% November 2009Entity G Cyber Israel 67% April 2012Entity H Distribution Hungary 100% January 2016Entity I Distribution Israel 100% January 2017The most significant NCIs (49%) are related to entity D. The profit and loss allocated to the NCI for 2022 amounts to $331 thousand (2021: $569 thousand

[paulisi] 12/4/2023 21:30

They also have the IP on the ventilators which are generating no revenue at Celitron.

[fse] 12/4/2023 21:21

BATM intend to sell the large contract Government Cyber business. I would expect that to happen any time. They are retaining to my understanding a commercial version of this which they have been developing. There is cyber bundling in Edgility which would stay.
They also plan to sell the medical distribution business.
The value of these two disposals is close to the entire current market cap of BATM.
Current market conditions may delay plans in this direction but I doubt by much so best guesstimate is this year.
There is talk of M&A for Edgility sales (non technical)

[resistance1] 12/4/2023 19:56

Bio/med waste business
Medical distribution business

[bigjon1] 12/4/2023 18:26

Nice insight FSE, good to get some quality posts back on the feed. Would love to hear people's opinion on which none-core divisions BATM will look to sell off? This is something I am going to look out for as well as how BATM use their large cash balance over the next few months - Exciting times ahead!

[fse] 12/4/2023 14:56

>resistance1..... Indeed the updated report addressed most of the concerns that Investors had. BATM developed its IP to the stage that it could have been sold off. They decided to hang onto it and now market the solutions themselves albeit with some key partners. This is a much more hands on approach that I had expected and it is a fundamental shift for the company away from being solely an R&D operation.
BATM was valued on the perceived worth of the IP now it is bringing this to market so its going to be valued on Sales and as an established company.

BATM did not force Zvi out rather the company has morphed to concentrate on Sales from what are now developed offerings. Moti is better suited at this stage to engage on the points you made above.
Zvi is I understand more involved with ADOR which itself is close to having marketable products.
BATM is actually making money prior to Edgility and ADOR platform contributing at all.

To my knowledge there are no disclosed short positions in BATM.

Added:

I have attached this chart for AUDC Audio Codes. Israeli company that BATM Telco deal with.
If you overlay BVC over AUDC they have performed the same way. There are a host of other companies like this with similar charts. Its not BATM specific



here's the 5 year BVC chart cant link the overlay but you get the point



OT .... I have filtered the trolls who do not have any position in the company whatsoever.

[kemche] 12/4/2023 14:33

Why is no one buying this? Do the II not read this board?